• Carvedilol: Applied β-Adrenergic Research Workflows

  2026-09-18

  Carvedilol combines nonselective β-adrenergic blockade with α1-adrenergic antagonism and measurable antioxidant activity, making it useful across receptor-signaling, vascular, oxidative-stress, and hematopoietic assays. This practical guide connects concentration selection, vehicle control, transplant-model design, and troubleshooting to findings from recent regeneration research.

• Tropifexor and the Gut–Liver Translation Gap

  2026-09-18

  Tropifexor (LJN452) gives translational researchers a highly potent, research-grade tool for testing how FXR activation shapes intestinal barrier biology and metabolic signaling. By placing FXR experiments alongside new evidence on triacetin digestion and hepatic AMPK responses, this article outlines a more rigorous strategy for connecting epithelial, hepatic, and nutrient-derived signals without overstating causality.

• Gastric Cancer Assembloids Model Tumor–Stroma Biology

  2026-09-17

  The reference study develops patient-derived gastric cancer assembloids by combining matched tumor organoids with autologous stromal cell subpopulations. Its results show that stromal composition alters gene expression and drug sensitivity, providing a more physiologically informative platform for resistance studies and personalized treatment evaluation.

• One-step TUNEL Cy3 Kit for Apoptosis

  2026-09-17

  The One-step TUNEL Cy3 Apoptosis Detection Kit uses terminal deoxynucleotidyl transferase (TdT) labeling to visualize apoptotic DNA fragmentation in cells and tissue sections. Its Cy3 signal supports fluorescence microscopy and flow cytometry, while DNase I and camptothecin controls provide practical assay benchmarks.

• D-Luciferin Potassium Salt for Cancer BLI

  2026-09-16

  D-Luciferin potassium salt enables repeatable firefly-luciferase readouts across tumor cell tracking, reporter assays, and ATP-linked workflows. Its water solubility supports practical in vivo bioluminescence imaging while offering a clean route to connect longitudinal tumor burden with mechanistic studies such as LNP-delivered miRNA research.

• RHEB Neddylation, mTORC1, and Liver Tumorigenesis

  2026-09-16

  The reference study identifies RHEB as a non-cullin substrate of the UBE2F–SAG neddylation machinery and shows that modification at K169 strengthens RHEB lysosomal localization and GTP binding. Genetic evidence links this axis to mTORC1 activity, liver steatosis, PTEN-loss-driven tumorigenesis, and survival-associated features of hepatocellular carcinoma.

• 3X FLAG Peptide Workflow Guide

  2026-09-15

  Build more reliable FLAG-tagged protein workflows with a small, hydrophilic 3X epitope designed for purification, detection, and structural biology. This guide combines practical protocol starting points with metal-aware assay controls and lessons from recent GM130 condensate research.

• GSH and GSSG Assay Kit: Redox Decisions in Hypoxia

  2026-09-15

  Explore how the GSH and GSSG Assay Kit supports reduced glutathione detection and mechanistically informed redox analysis in hypoxic tumor biology. This guide connects glutathione measurements with sample handling, immunometabolism, and interpretation beyond a simple GSH/GSSG ratio.

• One-step TUNEL Cy3 Apoptosis Detection Kit Guide

  2026-09-14

  Build a reproducible DNA fragmentation assay for tissue sections, adherent cells, suspension cells, and flow cytometry. This guide also shows how Cy3-based TUNEL readouts can complement mitochondrial-stress studies such as recent glioblastoma research.

• EdU Imaging Kits (488): S-Phase Detection

  2026-09-14

  EdU Imaging Kits (488) use 5-ethynyl-2'-deoxyuridine and click chemistry to label cells undergoing DNA synthesis. The workflow supports fluorescence microscopy and flow cytometry while avoiding DNA denaturation used in many BrdU protocols.

• EdU Imaging Kits (488) for NSCLC Proliferation

  2026-09-13

  EdU Imaging Kits (488) turn S-phase labeling into a morphology-preserving readout for cancer pharmacology, cell-cycle studies, and screening. This guide connects practical click-chemistry workflow choices with the 2026 Linarin–NSCLC study, highlighting how to distinguish reduced DNA synthesis from broader cytotoxicity.

• Endothelial Sp1/Sp3 in Captopril Blood Pressure Control

  2026-09-12

  This Nature Communications study shows that endothelial Sp1 and Sp3 are required for captopril-mediated blood-pressure control in male mice. Through inducible endothelial-specific gene deletion and molecular analyses, it links ACE inhibitor benefit to HDAC1-dependent stabilization of Sp1/Sp3, endothelial nitric oxide availability, vasodilation, and protection from cardiac remodeling.

• Sex Differences in Angiotensin II Hypertension

  2026-09-11

  Xue, Pamidimukkala, and Hay used radiotelemetry in conscious, freely moving mice to show that chronic angiotensin II produces a markedly larger pressor response in males than females. Gonadectomy, baroreflex testing, and ganglionic blockade further linked this divergence to sex-hormone effects, autonomic support of blood pressure, and sex-specific baroreflex adaptation.

• Z-VDVAD-FMK in Apoptosis Assays

  2026-09-11

  Z-VDVAD-FMK helps researchers separate caspase-2-associated apoptosis from caspase-independent and pyroptotic outcomes. This practical guide covers solvent handling, inhibitor controls, mitochondrial readouts, and assay decisions inspired by recent HOXC8–caspase-1 research.

• PPM-18: A Causal Map for NF-κB–iNOS Research

  2026-09-10

  PPM-18 provides a mechanistically focused way to study NF-κB-dependent iNOS expression and inflammatory signaling. This article connects its use to osteoimmune research while defining assay boundaries, orthogonal readouts, and translational limitations.

553 records 4/37 page Previous Next 12345 下5页 Last page